Straumann® TLX Implant System

Iconic Tissue Level meets Immediacy.

Buy now
Contact us

The design of the Straumann® TLX Implant takes into account key biological principles of hard and soft tissue healing.

Watch video
Visualize features and benefits
Designed for immediate protocols

Fully tapered implant design for optimized primary stability combined with the predictability of Tissue Level Implant. A narrow implant diameter option, 3.75 mm for all indications
Peri-implant health-preservation

Reduced risk of nesting bacteria. Optimized cleansability with the connection at the soft-tissue level. Immediate soft-tissue attachment preservation
Simplicity and efficiency

A one-stage process with restoration at soft-tissue level allows you to use chair time more efficiently. Ease of restoration even in the posterior region. Highly efficient treatment protocol thanks to straightforward conventional and digitally integrated workflows
Dynamic bone management

Redistribution of native bone and control over insertion torque
Real confidence

Swiss precision and quality with Roxolid® material and SLActive® surface

Straumann® TLX Digital Connectivity

Learn more

Brochures and videos

Looking for additional information? You'll find them in the Download Center.

register your interest

Data usage agreement*

Read our privacy notice.

Please retype the code above

References

1 Ioannidis A, Gallucci GO, Jung RE, Borzangy S, Hämmerle CH, Benic GI. Titanium-zirconium narrow-diameter versus titanium regulardiameter implants for anterior and premolar single crowns: 3-year results of a randomized controlled clinical study. J Clin Periodontol. 2015 Nov;42(11):1060-70. doi: 10.1111/jcpe.12468. Epub 2015 Nov 14.
2 Al-Nawas B, Domagala P, Fragola G, Freiberger P, Ortiz- Vigón A, Rousseau P, Tondela J. A Prospective Noninterventional Study to Evaluate Survival and Success of Reduced Diameter Implants Made From Titanium-Zirconium Alloy. J Oral Implantol. 2015 Aug;41(4):e118-25. doi: 10.1563/ AAID-JOI-D-13-00149. Epub 2014 Mar 25.
3 Altuna P, Lucas-Taulé E, Gargallo-Albiol J, Figueras-Álvarez O, Hernández-Alfaro F, Nart J. Clinical evidence on titanium-zirconium dental implants: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2016 Jul;45(7):842-50. doi: 10.1016/j.ijom.2016.01.004. Epub 2016 Feb 3.
4 Nicolau P, Guerra F, Reis R, Krafft T, Benz K , Jackowski J 10-year results from a randomized controlled multicenter study with immediately and early loaded SLActive implants in posterior jaws. Presented at 25th Annual Scientific Meeting of the European Association of Osseointegration – 29 Sep – 1 Oct 2016, Paris.
5 Nelson, K., Stricker, A., Raguse, J.-D. and Nahles, S. (2016), Rehabilitation of irradiated patients with chemically modified and conventional SLA implants: a clinical clarification. J Oral Rehabil, 43: 871–872. doi:10.1111/joor.12434.
6 Patients treated with dental implants after surgery and radio-chemotherapy of oral cancer. Heberer S, Kilic S, Hossamo J, Raguse J-D, Nelson K. Rehabilitation of irradiated patients with modified and conventional sandblasted, acid-etched implants: preliminary results of a split-mouth study. Clin. Oral Impl. Res. 22, 2011; 546–551.
7 Straumann (2016). SLActive® supports enhanced bone formation in a minipig surgical GBR model with coronal circumferential defects. Unpublished data.
8 Norm ASTM F67 (states min. tensile strength of annealed titanium); data on file for Straumann cold-worked titanium and Roxolid® implants.
9 Maniura K. Laboratory for Materials – Biology Interactions Empa, St. Gallen, Switzerland. Protein and blood adsorption on Ti and TiZr implants as a model for osseointegration. EAO 22nd Annual Scientific Meeting; October 17–19; 2013; Dublin.